Research reported to the meeting was concerned with the taxonomy and genetics of T. evansi, the cloning and sequencing of nuclear and kinetoplastic DNA (kDNA), chromosomal polymorphism in relation to antigenic variation, the detection of lymphocytic interleukin 2 and its receptors in infected ponies, the use of monoclonal group antibodies to detect T. evansi, and the importance of natural receptivity of the host.
INTRODUCTION
The Eleventh Meeting was attended by twelve participants from five countries and chaired by Dr J.W. Thomson of the Organisation of African Unity (OAU) and the Inter-African Bureau for Animal Resources (IBAR, Kenya) and advisor to Dr W.N. Masiga. A brief summary of the discussions was made available during the 58th General Session of the OIE. The following points were raised in the course of the Meeting: This outline of discussions did not attempt to summarise the activities of the Group since its creation in 1983, nor did it refer to the interim report of the Secretary, presented as two separate working documents and included in the proceedings presented below.
SUMMARY OF ACTIVITIES OF THE WORKING GROUP
In accordance with the objectives established at the First Meeting in May 1983 during the 51st General Session of the OIE (23) After each meeting, a draft report was compiled by the Secretary and sent to participants for corrections and/or amendments, before publication in the Scientific and Technical Review of the OIE between 1984 and 1990 (in the three official languages of the organisation).
The following results have been achieved: -collection of much epidemiological data for refining and expanding the distribution map for T. evansi in Africa and Asia; -free distribution of diagnostic kits for detecting T. evansi in the field, through the participation of the following specialist laboratories: and employing various techniques: direct microscopy improved by using a detergent, slide agglutination test, enzyme-linked immunosorbent assay (ELISA) for antibodies or antigens, and the card agglutination test with a cold probe (CATT); -greater interest by many countries in a more detailed study of T. evansi, either in relation to camel breeding (Morocco, Egypt, Ethiopia, Kenya, the Sudan, India, USSR) or in relation to other animals, e.g. buffaloes, cattle, goats, asses, horses and pigs (India, the People's Republic of China, Indonesia, Malaysia, Thailand, Vietnam, Venezuela); -research, synthesis and development of the first new trypanocide for thirty years, melarsomine (Cymerlarsan®) -active against T evansi and other members of the genus Trypanozoon and recommended for use in camels, buffaloes and cattle; -favourable laboratory tests of ronidazole (already used in veterinary therapy) against T. evansi, together with two other candidate products known as "IMOL 881" (Belgium) and "T 46" (People's Republic of China); -exchange of information with the International Commission on Zoological Nomenclature concerning possible revision of the nomenclature of the genus Trypanozoon.
INTERIM REPORT OF THE SECRETARY GENERAL
The report of the Tenth Meeting of the Group on 24 May 1989 was published in the Scientific and Technical Review of the OIE, 1990, Vol. 9 (4), 1209-1219, after incorporation of corrections submitted by the participants.
Information published in the literature
The period between May 1989 and May 1990 was marked by the increasing interest of Asian countries in T. evansi.,
In particular, much research was conducted:
-in India, on the subcellular structure of T. evansi (16) , antigen formation (17) , and on serological modifications (20) and lymphocytic changes (21) in infected buffalo calves; -in Indonesia, on the place of T. evansi among other blood parasites of cattle (15) and. survival of T. evansi in samples of buffalo blood (22) The following research has been conducted in Africa:
-in Somalia, on the seasonal incidence of blood parasites, including T. evansi in cattle (7), and trypanosomes (and their vectors) in camels (9).
-in Ethiopia, the testing of Cymerlarsan® on camels infected with T. evansi (24) .
-in the Sudan, in collaboration with researchers at the Centre for Tropical Veterinary Medicine (CTVM) in Edinburgh, United Kingdom, on immuno-enzyme techniques (ELISA) for diagnosing T. evansi infection in dromedaries (18) .
At the same time, research has continued in European countries on the detection of T. evansi infection. There have been reports on the use of CATT tests for serological diagnosis of T. evansi (3, 5), on their suitability for use in tropical countries (14) and on antigenic variability of T. evansi in rabbits (6) .
Other information
With the help of the French Institute for Research in Cooperative Development (ORSTOM) in Montpellier (France), links have been established with Bolivia for a Franco-Bolivian research programme on substances of vegetable origin active against trypanosomes and species of Leishmania. The Free University of Brussels has been consulted by the Colombian Veterinary Services on the possibility of controlling T. evansi infection in llamas.
Through the CTVM at Edinburgh, contact has been made between the Secretary of the Group and the Division of Biological Sciences at Simón Bolívar University, Caracas, on two major projects involving T. vivax and T. evansi infections in cattle in Venezuela. ELISA is already in use in Venezuela to diagnose T. evansi infection in horses. Research is also being conducted by this Division on cloning certain strains, their preservation and biochemical properties and on modifications to diagnostic tests.
In Egypt, tests for T. evansi infection in dromedaries and buffaloes are being developed by the Department of Parasitology of the Giza Veterinary Faculty, based on diagnostic kits (microscope identification with the use of a detergent, and/or agglutination-lysis on slides) kindly supplied by the Tropical Institute of Antwerp. After discussion, it was decided that the system of nomenclature presented at the previous meeting was the most appropriate.
MINUTES OF THE MEETING

Basic research
Professor Th. Baltz reported the results of cloning and sequencing obtained in his laboratory (Bordeaux University II) with Y.C. Ou on four strains of T. evansi from buffaloes and horses in the Philippines, the People's Republic of China (Jilin and Shanghai provinces) and Ethiopia.
Comparison of kinetoplastic DNA (kDNA) sequences demonstrated the heterogeneity of the strains (within the homogeneous group which characterises T. evansi), and probes specific for T. evansi were identified.
Professor R. Hamers reported a similar observation with strains from buffaloes and pigs in Thailand. Dr E. Bajyana-Songa used seven VSG (variant surface glycoprotein) probes to confirm by nuclear DNA analysis the finding derived from kDNA that all strains of T. evansi are members of a group which is very homogeneous in terms of sequential divergence. Moreover, their work showed that T. evansi is more closely related to West African T. brucei brucei and to T. brucei gambiense than to other African trypanosomes.
Professor N. Van Meirvenne confirmed the findings mentioned above and stressed the additional results: heterogeneity between individual strains within the same group of trypanosomes.
Other activities at specialist laboratories
Exchange of strains
Very few exchanges of strains between specialist laboratories have been reported since the formation of the Group. In the opinion of Dr L. Touratier, supported by Professor D. Mehlitz, this was a major gap to be filled. Comparison of numerous T. evansi strains of different geographical origin could lead to important developments:
-standardisation of diagnostic antigens; -studies of variability in drug resistance in different geographical areas, with reference to a single trypanocide or several trypanocides, utilising the latest techniques in biotechnology, which could elucidate failures in certain chemotherapeutic and/or chemoprophylactic schemes, and might lead to new active compounds. -polyclonal activation of pony lymphocytes by an antigen prepared from T. evansi. Stimulation of the lymphocytes enhanced the production of interleukin 2 (IL-2) and the expression of receptors for IL-2 (1). Further work, at present awaiting publication, dealt with the production of IL-2 and the expression of IL-2 receptors by lymphocytes in circulating blood of ponies, following stimulation by a soluble fraction of T. evansi. Dr A.G. Luckins and Dr R. Boid of CTVM (Edinburgh) were unable to be present, but Dr Touratier read the three summaries he had received from them, as follows:
Evaluation of diagnostic techniques and other research
-"An ELISA to detect T. evansi by using group-specific monoclonal antibodies" (A.G. Luckins et al.).
-"Importance of natural receptivity of the host to T. evansi infection" (T.W. Jones & CD. McKinnell).
-"Relationships between chromosome polymorphism in T. evansi and the range of antigenic variants" (R. Boid & T.W. Jones).
Regarding proposals for the OIE Manual of recommended diagnostic techniques and requirements for biological products: the text prepared by Dr P. Kageruka was adapted by Dr Y. Ozawa after a few minor changes for inclusion as Chapter 20 "Surra (T. evansi)" in Volume III of the Manual.
New epidemiological information
Brazil: according to Professor Mehlitz, it is now recognised and proven that capybaras (Hydrochoerus capybara) can act as a reservoir for T. evansi.
Colombia: as mentioned above, Drs Hamers and Bajyana-Songa have identified T. evansi in blood samples from llamas.
Southern Algeria and Southern Morocco: T. evansi infection in dromedaries ("debab") is frequently underestimated, according to a report presented by Professor A. Dakkak at the Maghreb Veterinary Conference in Algeria in May 1990. The infection, often insidious, has never been reported to the Veterinary Services, but camel owners are well aware of its existence and treat dromedaries at the least suspect symptom, using low doses of diminazene aceturate (Berenil). However, this is not a specific drug, and its use may result in a carrier state.
Trypanocidal drugs
Development of studies on melarsomine (Cymelarsan®) Dr J.P. Raynaud reported trials with melarsomine, initially on laboratory animals infected with camel strains of T. evansi and subsequently on experimentally and naturally infected dromedaries in Niger, Ethiopia, Kenya and the Sudan. He confirmed the results given at previous meetings of the Group concerning the toxicity, pharmacokinetics and biological availability of melarsomine in different species of animals, and its consistent efficacy against T. evansi in a single dose at 0.25-0.5 mg/kg body weight, administered by intramuscular or subcutaneous injection. Dr Raynaud recommended the dose rate of 0.25 mg/kg as giving the most consistent results. This move is particularly important as melarsomine will be the first effective trypanosomosis drug to be marketed since 1965, during which time many international organisations concerned with this disease and its consequences for developing countries have expressed the wish for an effective drug.
Other trypanocides under investigation
No information has been supplied by the Laboratory for Animal Parasitology at Shanghai on the chemical group to which compound "T 46" belongs. It was reported in 1989 that this compound was effective against T. evansi in buffaloes and cattle in the People's Republic of China.
Compound "IMOL 881", which showed promise after initial tests on laboratory animals at the Free University of Brussels, is still being evaluated.
Professor Kageruka reported good results following administration of ronidazole to rats in drinking water. This veterinary drug, available commercially for some time to combat haemorrhagic enteritis in pigs, protected all the experimental animals from T. evansi infection when given at 68 mg/kg body weight for nine consecutive days (13) . Trials on the target species will be undertaken.
OTHER TOPICS
Economic impact of T. evansi infections
Professor Mehlitz stressed the need to conduct surveys in order to discover the actual impact of T. evansi infections in various species of domestic animals. The diagnostic kits introduced by the Group, easy to use and cheap, could greatly assist the performance of such surveys.
Announcement of a meeting
First International Seminar on Animal Trypanosomoses Not Transmitted by Tsetse Flies, Annecy, 14-16 October 1992 This seminar is being sponsored by the OIE, the Food and Agriculture Organisation of the United Nations (FAO) and the World Health Organisation (WHO), with the participation of the Laveran Foundation and the Marcel Mérieux Foundation, which will provide accommodation for participants and a conference room. It will be organised jointly by this Working Group, CTVM (Edinburgh) and the Laboratory for Molecular Biology of Bordeaux University II. 
